EN
HI

MANKIND PHARMA Share price

MANKIND

HealthcareLarge

2572.7

12.80 (0.50%)
NSE
BSE
Last updated on 16 May, 2025 | 15:55 IST
BUYSELL
Today's High

2580.00

Today's Low

2532.00

52 Week Low

1901.05

52 Week High

3054.80

The current prices are delayed, login to your account for live prices

Mankind Pharma Chart

MANKIND PHARMA Fundamentals

P/E Ratio

54.14

P/B Ratio

7.46

Div. Yield

0

Sector P/E

41.98

Sector P/B

4.77

Sec. Div. Yield

0.33

MANKIND PHARMA Resistance and Support

Pivot 2549.67

Resistance

First Resistance

2583.34

Second Resistance

2606.77

Third Resistance

2640.44

Support

First Support

2526.24

Second Support

2492.57

Third Support

2469.14

MANKIND PHARMA Futures & Options

Data Not Found

MANKIND PHARMA Shareholding Pattern

    Total Promoters
    Segment
    Percent

    Total Promoters

    72.71%

    Mutual Fund

    7.83%

    Insurance

    2.21%

    Foreign Institutional Investors

    13.34%

    Domestic Institutional Investors

    1.02%

    Retail

    2.9%

    Others

    -0.01%

    Total Promoters
    MAR '24
    74.88%
    JUN '24
    74.87%
    SEP '24
    74.87%
    DEC '24
    72.71%

    MANKIND PHARMA Corporate Actions

    DateAgenda
    2025-05-21Audited Results
    2025-01-23Quarterly Results
    DateEvent TypeAgenda
    2025-05-21Board MeetingAudited Results
    2025-01-23Board MeetingQuarterly Results

    MANKIND PHARMA News

    Mankind Pharma inks licensing pact with Innovent to commercialise Sintilimab in India

    Dec 26 2024 19:21:53

    Mankind Pharma partners with Innovent to aid cancer treatment in India

    Dec 26 2024 12:06:53

    Mankind Pharma shares in focus after co launches Rs 3,000 crore QIP

    Dec 17 2024 09:36:52

    Dr Reddy's Labs, Mankind Pharma riding on strong growth drivers

    Nov 06 2024 16:42:04
    Read More

    About MANKIND PHARMA AboutThe

    NSE : 15380  
    BSE : 543904  
    ISIN : INE634S01028  

    Our Company was incorporated on July 3 1991 as a private limited company under the Companies Act 1956 with the name “Mankind Pharma Private Limited” pursuant to a certificate of incorporation granted by the Registrar of Companies Delhi and Haryana at New Delhi (“RoC”). Pursuant to the conversion of our Company to a public limited company and as approved by our Shareholders pursuant to a special resolution dated July 14 2005 the name of our Company was changed to “Mankind Pharma Limited” and the RoC issued a fresh certificate of incorporation on April 13 2006.Major events and milestones:2004 Entered the chronic pharmaceutical segment with the launch of ‘Amlokind’ tablets and ‘Glimestar’tablets amongst others2005 -Set up our first manufacturing facility at Paonta Sahib Himachal Pradesh-Entered the ophthalmic pharmaceutical segment with the launch of ‘Lubistar Eye Drops’ and ‘Tobastar Eye Drops’ amongst others2007 -Entered the consumer healthcare segment with the launch of ‘Manforce’ brand-Entered the animal healthcare segment with launch of ‘Bandykind’ and ‘Ceftiforce’ amongst othersRaised ? 720 million from Monet Limited2009 Set up our manufacturing facility at Unit II Paonta Sahib Himachal Pradesh2010 Launched ‘Preganews’ brand in the consumer healthcare segment2012 Setup our first R&D centre at IMT Manesar Haryana2014 -Acquired Shree Jee Laboratory Private Limited (along with its API manufacturing site situated at Behror Rajasthan)-Set up our manufacturing facility at Unit III Paonta Sahib Himachal Pradesh2015 -Incorporated our Subsidiary Lifestar Pharma LLC in the US-Incorporated our Subsidiary Mankind Pharma Pte. Limited in Singapore2017 Set up our manufacturing facility in Sikkim2018 Our manufacturing facility at Paonta Sahib Himachal Pradesh was inspected by the USFDA for the first time2019 Entered the female infertility segment with the launch of ‘Dydroboon’ tablets2020 -Incorporated our Subsidiary Lifestar Pharmaceuticals Private Limited in Nepal-Launched a dedicated specialty therapeutic division for cardiovascular diseases drugs segment with launch of ‘Cilaheart’ tablets and ‘Statpure’ tablets-Launched a dedicated specialty therapeutic division for diabetes pharmaceuticals segment with launch of ‘Zukanorm’ tablets2021 -Incorporated our Subsidiary Mankind Pharma FZ-LLC in Dubai UAE-Launched a specialty division for therapeutic respiratory pharmaceuticals with launch of ‘Mlife’ tablets-Entered the specialty therapeutic neuro/central nervous system pharmaceuticals segment with launch of ‘Trugaba-NT’ tablets and ‘Prebris-MNT’ tablets2022 -Acquired the pharmaceutical formulations brands in India and Nepal from Panacea Biotec Pharma Limited and Panacea Biotec Limited-Entered into transplant segment with the launch of ‘Pangraf Capsules’ and ‘Mycept’ tablets amongst others-Entered into oncology segment with the launch of ‘Pacliall’ injection amongst others-Acquired the brands ‘Daffy’ and ‘Combihale’ from Dr. Reddy’s Laboratories-Our Subsidiary Mankind Life Sciences Private Limited acquired 90.00% of the issued subscribed and paid-up share capital of Upakarma Ayurveda Private Limited.

    MANKIND PHARMA Management

    NamePosition
    Mr. Ramesh Juneja Chairman & Wholetime Director
    Mr. Rajeev Juneja Vice Chairman & Mng.Director
    Ms. Sheetal Arora WholeTime Director & CEO
    Mr. Satish Kumar Sharma Whole Time Director
    Mr. Vivek Kalra Independent Director
    Read More

    MANKIND PHARMA FAQs

    MANKIND PHARMA शेयर का खरीद मूल्य 2572.7 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

    MANKIND PHARMA शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

    MANKIND PHARMA शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 54.14 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

    MANKIND PHARMA शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 7.46 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    MANKIND PHARMA शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 4.77 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    MANKIND PHARMA का मार्केट कैप 106144.08 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

    MANKIND PHARMA शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 3054.80 और 1901.05 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

    MANKIND PHARMA Share Key Metrics

    Volume
    1.83 L
    Market Cap
    106144.08 CR
    LTQ@LTP
    1@2572.70
    ATP
    2553.75
    Var Margin
    16.57 %
    Circuit Range
    2048-3071.8
    Delivery %
    43.14 %
    Value
    46.64 CR
    ASM/GSM
    No
    Market Lot
    1